Leopalace21 Corp
TSE:8848
Leopalace21 Corp
TSE:8848
Price:
583
JPY
0.34%
Market Closed
Market Cap:
185.2B
JPY
Add
Note
Why Create Notes?
Capture your thoughts
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Peter Lynch
Track and Analyze Performance
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Continuous Learning and Adaptation
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
Boost Decision Confidence
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Delete Note
Do you really want to delete this note?
This action cannot be undone.
Alert
Leopalace21 Corp
583
+2 (+0.34%)
| 52 Week Range |
393
624
|
| Price Target |
|
We'll email you a reminder when the closing price reaches JPY.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
Delete Alert
This alert will be permanently deleted.
Ask me anything about
Leopalace21 Corp
Balance Sheet
Balance Sheet Decomposition
Leopalace21 Corp
Leopalace21 Corp
| Current Assets | 91.2B |
| Cash & Short-Term Investments | 76.6B |
| Receivables | 4.9B |
| Other Current Assets | 9.7B |
| Non-Current Assets | 117B |
| Long-Term Investments | 4.8B |
| PP&E | 60.7B |
| Intangibles | 1.2B |
| Other Non-Current Assets | 50.2B |
| Current Liabilities | 56.4B |
| Accounts Payable | 3.1B |
| Accrued Liabilities | 1.9B |
| Other Current Liabilities | 51.4B |
| Non-Current Liabilities | 75.1B |
| Long-Term Debt | 29.8B |
| Other Non-Current Liabilities | 45.3B |
Balance Sheet
Leopalace21 Corp
Leopalace21 Corp
Currency: JPY
| Mar-2015 | Mar-2016 | Mar-2017 | Mar-2018 | Mar-2019 | Mar-2020 | Mar-2021 | Mar-2022 | Mar-2023 | Mar-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
75 221
|
88 043
|
104 432
|
106 543
|
84 536
|
60 501
|
54 863
|
45 523
|
53 560
|
68 627
|
|
| Cash Equivalents |
75 221
|
88 043
|
104 432
|
106 543
|
84 536
|
60 501
|
54 863
|
45 523
|
53 560
|
68 627
|
|
| Short-Term Investments |
831
|
880
|
121
|
462
|
1 254
|
5 951
|
100
|
200
|
0
|
0
|
|
| Total Receivables |
11 917
|
11 074
|
10 222
|
10 854
|
9 929
|
9 002
|
10 177
|
7 536
|
6 236
|
6 358
|
|
| Accounts Receivables |
7 769
|
8 559
|
8 716
|
9 438
|
8 475
|
7 628
|
8 272
|
6 806
|
5 526
|
5 394
|
|
| Other Receivables |
4 148
|
2 515
|
1 506
|
1 416
|
1 454
|
1 374
|
1 905
|
730
|
710
|
964
|
|
| Inventory |
1 277
|
1 394
|
3 314
|
4 509
|
7 826
|
5 250
|
1 264
|
1 311
|
1 207
|
844
|
|
| Other Current Assets |
13 017
|
13 513
|
15 697
|
7 799
|
7 212
|
7 600
|
6 194
|
5 591
|
5 749
|
6 599
|
|
| Total Current Assets |
102 263
|
114 904
|
133 786
|
130 167
|
110 757
|
88 304
|
72 598
|
60 161
|
66 752
|
82 428
|
|
| PP&E Net |
169 430
|
172 036
|
155 267
|
143 344
|
123 215
|
85 534
|
70 052
|
64 652
|
61 364
|
59 137
|
|
| PP&E Gross |
169 430
|
0
|
155 267
|
143 344
|
123 215
|
85 534
|
70 052
|
64 652
|
61 364
|
59 137
|
|
| Accumulated Depreciation |
83 725
|
0
|
88 019
|
82 949
|
87 185
|
84 163
|
82 809
|
88 623
|
90 755
|
89 834
|
|
| Intangible Assets |
7 210
|
7 804
|
8 461
|
8 102
|
7 251
|
5 377
|
4 161
|
3 130
|
2 612
|
1 358
|
|
| Goodwill |
1 684
|
1 530
|
3 181
|
2 886
|
2 324
|
127
|
12
|
6
|
0
|
0
|
|
| Note Receivable |
1 837
|
0
|
1 762
|
1 777
|
715
|
1 250
|
1 345
|
1 393
|
759
|
779
|
|
| Long-Term Investments |
6 832
|
8 230
|
12 453
|
17 999
|
16 903
|
8 163
|
5 431
|
5 180
|
5 384
|
4 827
|
|
| Other Long-Term Assets |
19 018
|
21 305
|
22 918
|
32 859
|
30 625
|
8 198
|
8 109
|
10 908
|
29 677
|
56 471
|
|
| Other Assets |
1 684
|
1 530
|
3 181
|
2 886
|
2 324
|
127
|
12
|
6
|
0
|
0
|
|
| Total Assets |
308 274
N/A
|
327 609
+6%
|
337 828
+3%
|
337 134
0%
|
291 790
-13%
|
196 953
-33%
|
161 708
-18%
|
145 430
-10%
|
166 548
+15%
|
205 000
+23%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
2 803
|
2 606
|
2 826
|
4 245
|
4 037
|
3 376
|
3 172
|
2 552
|
2 549
|
2 875
|
|
| Accrued Liabilities |
0
|
5
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Short-Term Debt |
60
|
1 677
|
0
|
1 210
|
1 070
|
847
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
26 820
|
7 380
|
9 876
|
11 680
|
12 054
|
10 069
|
3 247
|
2 045
|
1 214
|
917
|
|
| Other Current Liabilities |
86 825
|
85 781
|
84 821
|
83 077
|
124 604
|
75 714
|
59 379
|
54 945
|
57 961
|
60 366
|
|
| Total Current Liabilities |
116 521
|
97 449
|
97 524
|
100 212
|
141 765
|
90 006
|
65 798
|
59 542
|
61 724
|
64 158
|
|
| Long-Term Debt |
17 606
|
41 766
|
40 041
|
40 938
|
34 922
|
25 219
|
32 159
|
30 998
|
30 634
|
29 962
|
|
| Deferred Income Tax |
135
|
208
|
148
|
0
|
5
|
5
|
9
|
11
|
13
|
0
|
|
| Minority Interest |
0
|
20
|
20
|
109
|
17
|
16
|
11 383
|
9 608
|
8 522
|
7 532
|
|
| Other Liabilities |
47 421
|
43 321
|
41 245
|
36 546
|
33 760
|
80 134
|
60 465
|
43 845
|
41 255
|
39 201
|
|
| Total Liabilities |
181 801
N/A
|
182 764
+1%
|
178 978
-2%
|
177 805
-1%
|
210 469
+18%
|
195 380
-7%
|
169 814
-13%
|
144 004
-15%
|
142 148
-1%
|
140 853
-1%
|
|
| Equity | |||||||||||
| Common Stock |
75 282
|
75 282
|
75 282
|
75 282
|
75 282
|
75 282
|
81 282
|
100
|
100
|
100
|
|
| Retained Earnings |
445
|
24 797
|
40 059
|
38 123
|
38 231
|
118 605
|
142 198
|
135 392
|
115 722
|
33 109
|
|
| Additional Paid In Capital |
51 501
|
45 235
|
45 235
|
45 235
|
45 148
|
45 148
|
55 174
|
136 345
|
136 240
|
30 121
|
|
| Unrealized Security Profit/Loss |
379
|
0
|
574
|
586
|
280
|
1 047
|
0
|
39
|
97
|
85
|
|
| Treasury Stock |
3 660
|
0
|
3 660
|
430
|
655
|
473
|
344
|
302
|
205
|
4 359
|
|
| Other Equity |
2 526
|
2 756
|
1 360
|
533
|
503
|
826
|
2 020
|
714
|
4 084
|
5 261
|
|
| Total Equity |
126 473
N/A
|
144 845
+15%
|
158 850
+10%
|
159 329
+0%
|
81 321
-49%
|
1 573
-98%
|
8 106
N/A
|
1 426
N/A
|
24 400
+1 611%
|
64 147
+163%
|
|
| Total Liabilities & Equity |
308 274
N/A
|
327 609
+6%
|
337 828
+3%
|
337 134
0%
|
291 790
-13%
|
196 953
-33%
|
161 708
-18%
|
145 430
-10%
|
166 548
+15%
|
205 000
+23%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
263
|
263
|
263
|
252
|
244
|
244
|
329
|
329
|
329
|
318
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
